(156) IMPACT AND PROVIDER SENTIMENT TOWARDS MANDATORY CHAPERONE POLICY DURING GENITOURINARY EXAMS: SURVEY OF A LARGE ACADEMIC UROLOGY PRACTICE
Reddy S, Cahill E, Heckscher D, Rotker K, Honig S. (156) IMPACT AND PROVIDER SENTIMENT TOWARDS MANDATORY CHAPERONE POLICY DURING GENITOURINARY EXAMS: SURVEY OF A LARGE ACADEMIC UROLOGY PRACTICE. The Journal Of Sexual Medicine 2024, 21: qdae167.153. DOI: 10.1093/jsxmed/qdae167.153.Peer-Reviewed Original ResearchAcademic urology practiceSexual medicine specialistsMedicine specialistsChaperone policyMedical chaperonesAdvanced practice providersRespondents expressed difficultyWeb-based surveyAssessment of patient perspectivesPractice providersUrological practiceClinical decision makingClinician workflowProvider sentimentClinician characteristicsPatient perspectiveClinician perspectivesPatient comfortPatients' perceptionsPatient visitsMedicolegal riskMedical assistancePerceived benefitsGenitourinary examinationMedicolegal perspective(333) TRENDS IN PHOSPHODIESTERASE TYPE 5 INHIBITOR PRESCRIPTIONS AND COST: MEDICARE ANALYSIS 2017-2021
Cahill E, Reddy S, Rotker K, Honig S. (333) TRENDS IN PHOSPHODIESTERASE TYPE 5 INHIBITOR PRESCRIPTIONS AND COST: MEDICARE ANALYSIS 2017-2021. The Journal Of Sexual Medicine 2024, 21: qdae167.321. DOI: 10.1093/jsxmed/qdae167.321.Peer-Reviewed Original ResearchPhosphodiesterase type 5Non-urologistsPDE5 inhibitorsPhosphodiesterase type 5 inhibitorsMedicare Part D databaseMedicare Part D Public Use FilesCompared urologistsPrescribed tadalafilPrescribed sildenafilSildenafil prescriptionsCost of medicationsErectile dysfunctionInhibitor medicationPrescribing patternsUrologistsPatient comfortPrimary care providersSildenafilTadalafilType 5